BF.B
48
-2
HIG
68
5
INTC
43
6
URI
46
3
AIV
37
-2
IRM
41
10
NWS
60
2
ORCL
33
7
IR
58
3
APD
45
-2
PYPL
52
2
WYNN
50
2
CF
48
4
CNX
49
3
AVGO
54
12
ADM
47
2
ROP
38
-4
KIM
50
-3
XEL
37
-2
STT
62
3
BF.B
48
-2
HIG
68
5
INTC
43
6
URI
46
3
AIV
37
-2
IRM
41
10
NWS
60
2
ORCL
33
7
IR
58
3
APD
45
-2
PYPL
52
2
WYNN
50
2
CF
48
4
CNX
49
3
AVGO
54
12
ADM
47
2
ROP
38
-4
KIM
50
-3
XEL
37
-2
STT
62
3
Financhill
Back

ProShares Ultra Silver Vs. Halozyme Therapeutics, Inc. Sector Stock Comparison

Buy
86

AGQ
ProShares Ultra Silver

Last Price:
$147.30
Seasonality Move:
4.35%
Buy
80

HALO
Halozyme Therapeutics, Inc.

Last Price:
$67.36
Seasonality Move:
8.36%
Buy
86
ProShares Ultra Silver (AGQ) is a Buy

Is ProShares Ultra Silver a Buy, Sell or Hold?

  • The current ProShares Ultra Silver [AGQ] share price is $147.33. The Score for AGQ is 86, which is 72% above its historic median score of 50, and infers lower risk than normal.
  • AGQ is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
80
Halozyme Therapeutics, Inc. (HALO) is a Buy

Is Halozyme Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Halozyme Therapeutics, Inc. [HALO] share price is $67.35. The Score for HALO is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • HALO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

AGQ Stock Price Chart

What is ProShares Ultra Silver's stock price today?

  • The ProShares Ultra Silver share price today is $147.33
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AGQ is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics, Inc.'s stock price today?

  • The Halozyme Therapeutics, Inc. share price today is $67.35
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HALO is experiencing buying pressure, which is a positive indicator for future bullish movement.

AGQ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 14.01 Buy
Relative Strength Index (14 RSI): 72.88 Buy
Chaikin Money Flow: 2410297 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (90.5 - 131.34) Buy
Bollinger Bands (100): (54.73 - 103.29) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.98 Sell
Relative Strength Index (14 RSI): 54.27 Buy
Chaikin Money Flow: 2772773 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.16 - 70.78) Buy
Bollinger Bands (100): (64.01 - 73.67) Sell

AGQ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 135.21 Buy
20-day SMA: 117.1 Buy
50-day SMA: 97.1 Buy
200-day SMA: 61.78 Buy
8-day EMA: 135.06 Buy
20-day EMA: 120.75 Buy
50-day EMA: 101.72 Buy
200-day EMA: 69.82 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.11 Buy
20-day SMA: 66.22 Buy
50-day SMA: 66.97 Buy
200-day SMA: 63.39 Buy
8-day EMA: 65.02 Buy
20-day EMA: 65.65 Buy
50-day EMA: 66.96 Buy
200-day EMA: 63.68 Buy

ProShares Ultra Silver Earnings Growth & AGQ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics, Inc. Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.15 per share, and an increase next year of $1.86 per share.

ProShares Ultra Silver Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):